Patent · US Active

Modified growth hormone polypeptides

US8273552B2 · kind B2 · utility

2Cited by

0References

22Claims

0Family size

Assignee

ASTERION LIMITED · GB

Inventors

Peter Artymiuk · Sheffield, GB
Richard Ross · Weston, US
Jon Sayers · Clay Cross, GB

Key dates

Filing date	Sep 10, 2008
Grant date	Sep 25, 2012
Priority date	—
Expiry date	Feb 8, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

We describe modified growth hormone fusion proteins and dimers comprising said fusion proteins; nucleic acid molecules encoding said proteins and methods of treatment that use said proteins in the treatment of conditions that result from growth hormone excess.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.